LSD plus psychotherapy may benefit dying patients, study says

03/18/2014 | Medscape (free registration)

The first controlled study of the use of lysergic acid diethylamide as part of psychotherapy in more than 40 years found it may help reduce anxiety in patients with terminal illness, according to Swiss investigators. Researchers writing in the Journal of Nervous and Mental Disease said the results of the 12-person pilot study, in which eight patients received LSD, warrant larger controlled trials.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA